TY  - GEN
AU  - Hümmert,Martin W
AU  - Deppe,Julian
AU  - Pul,Refik
AU  - Wurster,Ulrich
AU  - Schwenkenbecher,Philipp
AU  - Sühs,Kurt-Wolfram
AU  - Bronzlik,Paul
AU  - Stangel,Martin
AU  - Skripuletz,Thomas
TI  - Severe CNS inflammation after discontinuation of natalizumab and start of daclizumab successfully treated with alemtuzumab
SN  - 2211-0356
PY  - 2018///1011
KW  - Adult
KW  - Alemtuzumab
KW  - therapeutic use
KW  - Antibodies, Monoclonal, Humanized
KW  - adverse effects
KW  - Brain Stem
KW  - diagnostic imaging
KW  - Daclizumab
KW  - Drug Substitution
KW  - Female
KW  - Humans
KW  - Immunoglobulin G
KW  - Immunologic Factors
KW  - Inflammation
KW  - etiology
KW  - Multiple Sclerosis
KW  - Natalizumab
N1  - Publication Type: Case Reports; Journal Article
UR  - https://doi.org/10.1016/j.msard.2018.03.021
ER  -